| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,444 |
17,120 |
$1.85M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,330 |
12,054 |
$482K |
| 99215 |
Prolong outpt/office vis |
3,665 |
3,371 |
$471K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,658 |
4,467 |
$398K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,235 |
4,121 |
$384K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,037 |
5,470 |
$381K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,851 |
2,756 |
$258K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
10,587 |
10,274 |
$138K |
| 96127 |
|
5,663 |
5,319 |
$119K |
| D0145 |
Oral evaluation for a patient under three years of age |
3,150 |
3,110 |
$99K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
7,620 |
7,043 |
$79K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
722 |
684 |
$73K |
| 97803 |
|
3,325 |
3,207 |
$72K |
| 94761 |
|
14,916 |
12,029 |
$63K |
| 97802 |
|
2,106 |
2,067 |
$57K |
| D0190 |
|
3,397 |
3,342 |
$54K |
| 99381 |
|
629 |
582 |
$53K |
| 99173 |
|
6,222 |
5,982 |
$43K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
1,101 |
1,066 |
$33K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
163 |
42 |
$31K |
| 94760 |
|
15,425 |
13,398 |
$30K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
210 |
205 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
813 |
727 |
$14K |
| 99000 |
|
4,171 |
3,828 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
686 |
645 |
$8K |
| 85018 |
|
3,664 |
3,431 |
$8K |
| 36416 |
|
3,844 |
3,436 |
$7K |
| G0312 |
Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes) |
201 |
191 |
$6K |
| 94664 |
|
447 |
431 |
$6K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
58 |
56 |
$6K |
| 99354 |
|
66 |
63 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
133 |
132 |
$5K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
468 |
355 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
148 |
144 |
$2K |
| 99401 |
|
71 |
64 |
$2K |
| 90620 |
|
136 |
130 |
$2K |
| 99383 |
|
12 |
12 |
$1K |
| 90710 |
|
345 |
344 |
$1K |
| 87428 |
|
13 |
13 |
$1K |
| 90461 |
|
2,655 |
2,540 |
$960.64 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
87 |
86 |
$936.66 |
| 99417 |
Prolong home eval add 15m |
17 |
16 |
$827.83 |
| 99050 |
|
93 |
88 |
$782.10 |
| 90670 |
|
1,370 |
1,358 |
$726.75 |
| 90734 |
|
16 |
13 |
$715.96 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
375 |
341 |
$541.20 |
| 90686 |
|
1,088 |
1,076 |
$515.79 |
| 81002 |
|
162 |
152 |
$508.72 |
| 90698 |
|
825 |
816 |
$480.81 |
| 90633 |
|
539 |
537 |
$362.91 |
| 90696 |
|
95 |
95 |
$318.65 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
30 |
29 |
$196.97 |
| 1003F |
|
655 |
641 |
$188.40 |
| 90744 |
|
432 |
428 |
$147.39 |
| 90680 |
|
784 |
779 |
$101.29 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
99 |
96 |
$89.95 |
| 99415 |
Prolong outpt/office vis |
12 |
12 |
$88.32 |
| 90672 |
|
107 |
102 |
$83.37 |
| 96161 |
|
1,578 |
1,366 |
$57.01 |
| 94150 |
|
31 |
29 |
$47.44 |
| S9470 |
Nutritional counseling, dietitian visit |
73 |
70 |
$35.00 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
17 |
15 |
$33.04 |
| 90660 |
|
30 |
30 |
$25.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
30 |
30 |
$23.71 |
| 90658 |
|
13 |
12 |
$18.62 |
| H0033 |
Oral medication administration, direct observation |
387 |
376 |
$15.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
398 |
387 |
$13.23 |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
12 |
12 |
$6.27 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
30 |
30 |
$4.14 |
| G2121 |
Depression, anxiety, apathy, and psychosis assessed |
2,851 |
2,804 |
$0.00 |
| 90697 |
|
290 |
289 |
$0.00 |
| 90619 |
|
14 |
14 |
$0.00 |
| 90674 |
|
13 |
13 |
$0.00 |
| 90656 |
|
14 |
14 |
$0.00 |
| 90647 |
|
15 |
15 |
$0.00 |
| 90671 |
|
429 |
422 |
$0.00 |
| 90715 |
|
38 |
37 |
$0.00 |
| 90661 |
|
101 |
101 |
$0.00 |
| 90700 |
|
27 |
27 |
$0.00 |
| S9441 |
Asthma education, non-physician provider, per session |
14 |
13 |
$0.00 |